Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk diseaseSusan Branford, Timothy P. Hughes, Jinghua Feng et al.|Blood|2018Cited by 208
Early BCR-ABL1 kinetics are predictive of subsequent achievement of treatment-free remission in chronic myeloid leukemiaNaranie Shanmuganathan, Timothy P. Hughes, Ilaria S. Pagani et al.|Blood|2020Cited by 86
Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cellsTimothy P. Hughes, David M. Ross, Ilaria S. Pagani et al.|Leukemia|2018Cited by 78
Successful treatment‐free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cellsYazad Irani, Agnes S. M. Yong, Amy Hughes et al.|British Journal of Haematology|2020Cited by 77
Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remissionIlaria S. Pagani, David M. Ross, Phuong Dang et al.|Leukemia|2019Cited by 51